NEW
YORK, Aug. 9, 2024 /PRNewswire/ -- The global
capillary electrophoresis market size is estimated to grow by
USD 308 million from 2024-2028,
according to Technavio. The market is estimated to grow at a CAGR
of 5.66% during the forecast period. Increasing R and D
expenditure is driving market growth, with a trend
towards rise in proteomic research activities.
However, presence of alternative technologies poses a
challenge. Key market players include Agilent Technologies Inc.,
Bio Rad Laboratories Inc., Bio Techne Corp., BIOPTIC.INC, Cleaver
Scientific Ltd., Danaher Corp., Helena Laboratories Corp., LABGENE
Scientific SA, Lumex Instruments, Merck KGaA, Perkin Elmer Inc.,
Prince Technologies B.V., Promega Corp., QIAGEN NV, Sartorius AG,
SEBIA SA, SERVA Electrophoresis
GmbH, Sysmex Nederland B.V., Thermo Fisher Scientific Inc., and
WynSep.
Get a detailed analysis on regions, market
segments, customer landscape, and companies- View the
snapshot of this report
Capillary
Electrophoresis Market Scope
|
Report
Coverage
|
Details
|
Base year
|
2023
|
Historic
period
|
2018 - 2022
|
Forecast
period
|
2024-2028
|
Growth momentum &
CAGR
|
Accelerate at a CAGR of
5.66%
|
Market growth
2024-2028
|
USD 308
million
|
Market
structure
|
Fragmented
|
YoY growth 2022-2023
(%)
|
5.28
|
Regional
analysis
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Performing market
contribution
|
North America at
33%
|
Key
countries
|
US, Germany, France,
China, and Japan
|
Key companies
profiled
|
Agilent Technologies
Inc., Bio Rad Laboratories Inc., Bio Techne Corp., BIOPTIC.INC,
Cleaver Scientific Ltd., Danaher Corp., Helena Laboratories Corp.,
LABGENE Scientific SA, Lumex Instruments, Merck KGaA, Perkin Elmer
Inc., Prince Technologies B.V., Promega Corp., QIAGEN NV, Sartorius
AG, SEBIA SA, SERVA Electrophoresis GmbH, Sysmex Nederland B.V.,
Thermo Fisher Scientific Inc., and WynSep
|
Market Driver
The demand for personalized medicines, particularly in the
oncology therapeutic area, is driving the growth of the proteomics
research market. Proteins play crucial roles in the body, and
defects in their structures can lead to various disorders and
conditions. Personalized medicines offer targeted drug development
opportunities by identifying and studying protein expressions.
Pharmaceutical companies are increasingly shifting towards
personalized medicines due to their potential for better patient
management. Capillary electrophoresis is a preferred technique for
proteomics research due to its automation, reproducibility, and
minimal protein damage. This method allows for the identification
and characterization of proteins, providing valuable insights into
disease mechanisms. The discovery of new protein biomarkers and the
development of novel drugs for neurodegenerative, cardiovascular,
and chronic diseases, such as cancer, have significantly
contributed to the market's growth. Capillary electrophoresis's
advantages, including its ability to handle liquid polymers and
avoid gel handling, make it an essential tool in proteomics
research, further fueling market expansion.
The Capillary Electrophoresis (CE) market is experiencing
significant growth due to its application in various fields of
molecular biology. Weather patterns and mass population movements
have increased the demand for CE in pathogen detection and viral
load estimation for disease outbreaks. CE plays a crucial role in
drug development by enabling the separation and analysis of
biomarkers, tailoring treatment through protein and nucleic acid
analysis, and sequencing. Highly developed laboratories, academic
research groups, and skilled professionals rely on CE for its
automation and high throughput capabilities. CE-mass spectrometry
is a key technology for protein separation and analysis in clinical
laboratories. The market includes consumables, research &
development, and applications such as antibiotic therapy selection,
antiviral therapy selection, diagnosis of cancer, and prognostic
assessments. The high capital requirement for CE systems limits
market penetration, but the potential for personalized medicine and
advances in nucleic acid and protein analysis make it a valuable
investment for research fields.
Discover 360° analysis of this market. For
complete information, schedule your consultation - Book
Here!
Market Challenges
- The capillary electrophoresis market faces significant
competition from alternative technologies, particularly mass
spectrometry, which offers improved efficiency and results for
protein and nucleic acid separation and analysis. Mass spectrometry
identifies and analyzes components in a substance, determining its
structure, mass, and composition. Simultaneously locating thousands
of molecules within a sample or tissue eliminates the need to
target specific molecules, expediting the pre-clinical trial
process. Mass spectrometry's ability to observe oligomers and
their formation is crucial in understanding diseases like
Alzheimer's and Parkinson's. Although combination instruments like
CE-MS provide the benefits of both techniques, market growth may be
limited due to end-users' unfamiliarity with these advanced
technologies. Vendors' marketing initiatives promoting the use of
combination techniques could potentially expand the market in the
future.
- The Capillary Electrophoresis (CE) market faces several
challenges, including uncertain reimbursement scenarios for
CE-based tests. Reimbursement policies vary greatly, making it
difficult for companies to invest in research and development.
However, there are opportunities for growth through government and
private support in areas like cancer research and molecular
diagnostics. Advanced CE technologies, such as Capillary Electro
Chromatography and NGS Fragment Analysis, are driving innovation in
genomic DNA and plasmid DNA analysis. CE techniques are also being
used to diagnose infectious diseases and genetic disorders.
Industry-academic exploration collaborations are crucial for
advancing CE technologies in areas like nanoproteomics, forensics,
and Next-Generation Sequencing (NGS). CE plays a significant role
in drug discovery, from DNA sequencing to individualized treatment,
and is used to analyze DNA, RNA, and protein molecules. The market
also caters to various industries, including biotechnology,
genomics, and pharmaceuticals, with applications in tobacco use,
alcohol use, poor diet, inactivity, air pollution, and DNA analysis
for diseases like rectal cancer. CE is a versatile tool for
analyzing a wide range of samples, from agarose gel electrophoresis
to capillary zone electrophoresis, capillary gel electrophoresis,
capillary electrochromatography, and polyacrylamide gel
electrophoresis. CE is also used to analyze communicable diseases
and plant-based drug development, and has potential applications in
genome-based drug discovery and tailored therapeutics.
Infrastructure and expertise are key to driving growth in the CE
market.
For more insights on driver and
challenges - Request a sample report!
Segment Overview
This capillary electrophoresis market report extensively covers
market segmentation by
- End-user
- 1.1 Capillary zone electrophoresis
- 1.2 Capillary gel electrophoresis
- 1.3 Capillary electrochromatography
- Technique
- 2.1 Academic institutes and CROs
- 2.2 Pharma and biotech companies
- 2.3 Others
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Capillary zone electrophoresis- The Capillary
Electrophoresis market is experiencing significant growth due to
its ability to provide accurate and high-resolution separation of
DNA, proteins, and other biomolecules. This technology is widely
used in various industries including pharmaceuticals,
biotechnology, and food testing. Its advantages such as automation,
high-throughput, and cost-effectiveness make it a preferred choice
for laboratories worldwide. Companies like Agilent Technologies,
Thermo Fisher Scientific, and Bio-Rad Laboratories dominate the
market with their innovative products and solutions.
For more information on market segmentation with geographical
analysis including forecast (2024-2028) and historic data
(2017-2021) - Download a Sample Report
Learn and explore more about Technavio's in-depth research
reports
The global metabolomics market is experiencing robust growth,
driven by advancements in analytical technologies and increasing
research in personalized medicine. Key drivers include the rising
demand for biomarker discovery and drug development, along with
significant investments in pharmaceutical R&D. Segmentation
includes platforms, applications, and end-users, with North America leading the market, followed by
Europe and Asia-Pacific. Major players include Thermo
Fisher Scientific, Agilent Technologies, and Waters
Corporation.
Research Analysis
Capillary Electrophoresis (CE) is a versatile analytical
technique used in various fields, including biotechnology,
genomics, and molecular biology, for the separation,
identification, and quantification of nucleic acids and proteins.
CE is particularly valuable in the analysis of nucleic acid
sequences, such as genomic DNA, plasmid DNA, and NGS fragment
analysis, for applications like pathogen detection, viral load
estimation, antibiotic therapy selection, antiviral therapy
selection, diagnosis of cancer, and prognostic assessments. CE is
also used in DNA analysis for the detection of diseases associated
with lifestyle factors like tobacco use, alcohol use, poor diet,
inactivity, and air pollution. The technique is also used in rectal
cancer diagnosis and research. CE operates based on the principle
of Capillary Electro Chromatography, where an electric field is
applied to move charged particles through a capillary tube filled
with a buffer solution. This results in the separation of the
particles based on their size and charge. CE is a powerful tool in
the field of nucleic acid analysis and continues to play a
significant role in advancing our understanding of various diseases
and improving diagnostic capabilities.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- End-user
-
- Capillary Zone Electrophoresis
- Capillary Gel Electrophoresis
- Capillary Electrochromatography
- Technique
-
- Academic Institutes And CROs
- Pharma And Biotech Companies
- Others
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/capillary-electrophoresis-market-size-is-set-to-grow-by-usd-308-million-from-2024-2028-increasing-r-and-d-expenditure-boost-the-market-technavio-302217904.html
SOURCE Technavio